Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab

Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab

Abstract Background Small cell bladder carcinoma (SCBC) is a rare and aggressive malignant tumor with no established treatment guidelines. Its treatment algorithm has been based on the small cell lung cancer (SCLC) guidelines. Metastatic SCBC has poor prognosis (even when treated with platinum-based...

Full description

Bibliographic Details
Main Authors: Rei Kamitani, Toshiyuki Ando, Kazuya Hanai, Arihito Tanaka, Fumihiro Kashizaki, Yasutomo Sekido, Ryuichi Mizuno
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Urology
Subjects:
Small cell carcinoma
Bladder cancer
Atezolizumab
Complete response
Case report
Online Access:https://doi.org/10.1186/s12894-022-01130-4

Internet

https://doi.org/10.1186/s12894-022-01130-4

Similar Items